Login / Signup

Increased Plasma Kynurenic Acid Levels are Associated with Impaired Attention/Vigilance and Social Cognition in Patients with Schizophrenia.

Xingbing HuangWenhua DingFengchun WuSumiao ZhouShuhua DengYuping Ning
Published in: Neuropsychiatric disease and treatment (2020)
Our results indicate that elevated plasma KYNA levels may serve as a biomarker of cognitive impairment in SCZ patients.
Keyphrases
  • cognitive impairment
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • healthcare
  • working memory
  • prognostic factors
  • multiple sclerosis